StockData
Cadre Holdings, Inc. logo

Cadre Holdings, Inc. (CDRE) stock

CDRENYSEOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 16/3024% above fair value
$31.88−0.53 (-1.64%)

Close on Nov 18, 2026Market cap $1.37BP/E 39.4Yield 1.19%

Cadre operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

Cadre's operating income for the twelve months ending Jun 30, 2026 was $69.07M, up 9.5% year over year. For fiscal 2025 it was $67.35M, up 0.9% from the year before. The highest annual figure on record is $67.35M in fiscal 2025.

Annual operating income

PeriodPeriod endValueChange
FY2025Dec 31, 2025$67.35M+0.9%
FY2024Dec 31, 2024$66.76M+18.1%
FY2023Dec 31, 2023$56.52M+238.1%
FY2022Dec 31, 2022$16.72M-67.7%
FY2021Dec 31, 2021$51.72M+3.8%
FY2020Dec 31, 2020$49.80M–

Quarterly operating income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$22.46M+53.0%
Q1 FY2026Mar 31, 2026$7.49M-44.7%
Q4 FY2025Dec 31, 2025$20.44M-30.5%
Q3 FY2025Sep 30, 2025$18.67M+244.2%
Q2 FY2025Jun 30, 2025$14.69M-26.4%
Q1 FY2025Mar 31, 2025$13.55M+13.1%
Q4 FY2024Dec 31, 2024$29.40M+131.9%
Q3 FY2024Sep 30, 2024$5.43M-67.6%
Q2 FY2024Jun 30, 2024$19.95M+25.6%
Q1 FY2024Mar 31, 2024$11.98M+6.8%
Q4 FY2023Dec 31, 2023$12.68M-0.4%
Q3 FY2023Sep 30, 2023$16.73M+62.2%
Q2 FY2023Jun 30, 2023$15.89M+94.8%
Q1 FY2023Mar 31, 2023$11.22M–
Q4 FY2022Dec 31, 2022$12.72M+36.5%
Q3 FY2022Sep 30, 2022$10.32M-10.6%
Q2 FY2022Jun 30, 2022$8.16M-47.1%
Q1 FY2022Mar 31, 2022-$14.48M-193.8%
Q4 FY2021Dec 31, 2021$9.32M+0.3%
Q3 FY2021Sep 30, 2021$11.54M-9.5%
Q2 FY2021Jun 30, 2021$15.42M–
Q1 FY2021Mar 31, 2021$15.43M–
Q4 FY2020Dec 31, 2020$9.29M–
Q3 FY2020Sep 30, 2020$12.76M–

More Cadre figures

See a number that looks wrong?